LAPORTE KATHLEEN has filed 75 insider transactions across 5 companies since February 2023.
Most recent transaction: a grant/award of 23272 shares of Q32 Bio Inc. ($QTTB) on January 15, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 15, 2026 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 23272 | $2.75 | 23,272.0000 | 12,304,352 | 9999.99% | 0.19% |
| Jan. 15, 2026 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Common Stock | 520 | $24.00 | 7,382.0000 | 1,637,486 | 7.58% | 0.03% |
| Jan. 7, 2026 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 690900 | $0.00 | 690,900.0000 | 1,264,884 | 9999.99% | 54.62% |
| Jan. 2, 2026 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 1500 | $0.00 | 1,500.0000 | 1,637,486 | 9999.99% | 0.09% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Director Stock Option (Right to Buy) | 1100 | $0.00 | 1,100.0000 | 1,919,441 | 9999.99% | 0.06% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | D | Director Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Director Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 1,919,441 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | D | Director Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Director Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 1,919,441 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | D | Director Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Director Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 1,919,441 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | D | Director Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Director Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 1,919,441 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Director Stock Option (Right to Buy) | 1392 | $0.00 | 1,392.0000 | 1,919,441 | 9999.99% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | D | Director Stock Option (Right to Buy) | 1392 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.07% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | D | Director Stock Option (Right to Buy) | 1100 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.06% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Director Stock Option (Right to Buy) | 1100 | $0.00 | 1,100.0000 | 1,919,441 | 9999.99% | 0.06% |
| Dec. 12, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | D | Director Stock Option (Right to Buy) | 1100 | $0.00 | 0.0000 | 1,919,441 | 100.00% | 0.06% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 23, 2025 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 15, 2025 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Common Stock | 711 | $17.58 | 6,862.0000 | 1,637,486 | 11.56% | 0.04% |
| Sept. 8, 2025 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | S | Common Stock | 6152 | $20.06 | 6,151.0000 | 1,602,438 | 50.00% | 0.38% |
| May 27, 2025 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 1100 | $0.00 | 1,100.0000 | 38,339,697 | 9999.99% | 0.00% |
| May 30, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 9326 | $0.00 | 9,326.0000 | 3,427,616 | 9999.99% | 0.27% |
| April 15, 2025 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Common Stock | 2232 | $5.60 | 12,303.0000 | 1,502,652 | 22.16% | 0.15% |
| March 4, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 17923 | $0.00 | 17,923.0000 | 579,432 | 9999.99% | 3.09% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 1947 | $0.00 | 1,947.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 5431 | $0.00 | 5,431.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 1947 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 5431 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 127500 | $0.00 | 255,000.0000 | 579,432 | 100.00% | 22.00% |
| Feb. 3, 2025 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| Jan. 14, 2025 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 1000 | $0.00 | 1,000.0000 | 1,465,518 | 9999.99% | 0.07% |
| Dec. 2, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 127500 | $0.00 | 127,500.0000 | 24,838 | 9999.99% | 100.00% |
| Sept. 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | M | Series A Convertible Preferred Stock | 50 | $1000.00 | 0.0000 | 8,099 | 100.00% | 0.62% |
| Sept. 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | M | Common Stock | 965997 | $0.00 | 971,825.0000 | 8,099 | 9999.99% | 100.00% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 250 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.02% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 200 | $0.00 | 200.0000 | 1,463,543 | 9999.99% | 0.01% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 200 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.01% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 375 | $0.00 | 375.0000 | 1,463,543 | 9999.99% | 0.03% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 375 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.03% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 70 | $0.00 | 70.0000 | 1,463,543 | 9999.99% | 0.00% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 70 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.00% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 28 | $0.00 | 28.0000 | 1,463,543 | 9999.99% | 0.00% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 28 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.00% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 250 | $0.00 | 250.0000 | 1,463,543 | 9999.99% | 0.02% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 188 | $0.00 | 188.0000 | 1,463,543 | 9999.99% | 0.01% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 188 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.01% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 75 | $0.00 | 75.0000 | 1,463,543 | 9999.99% | 0.01% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 75 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.01% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 2000 | $0.00 | 2,000.0000 | 1,463,543 | 9999.99% | 0.14% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 2000 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.14% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 1,463,543 | 9999.99% | 0.09% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.09% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 1,463,543 | 9999.99% | 0.09% |
| Aug. 31, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | D | Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 1,463,543 | 100.00% | 0.09% |
| June 21, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 1000 | $0.00 | 1,000.0000 | 1,423,942 | 9999.99% | 0.07% |
| June 12, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| April 15, 2024 | Precipio, Inc. | $PRPO | LAPORTE KATHLEEN | Director | A | Common Stock | 9693 | $6.70 | 10,071.0000 | 1,423,942 | 2564.29% | 0.68% |
| March 25, 2024 | Q32 Bio Inc. | $QTTB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 112500 | $0.00 | 112,500.0000 | 292 | 9999.99% | 100.00% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Series A Convertible Preferred Stock | 50 | $1000.00 | 50.0000 | 292 | 9999.99% | 17.12% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | A | Series A Convertible Preferred Stock | 50 | $1000.00 | 50.0000 | 292 | 9999.99% | 17.12% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | LAPORTE KATHLEEN | Director | J | Common Stock | 5828 | $0.00 | 5,828.0000 | 292 | 9999.99% | 100.00% |
| Feb. 1, 2024 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| July 17, 2023 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | M | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 34,806,349 | 50.00% | 0.04% |
| July 17, 2023 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | S | Common Stock | 12500 | $18.80 | 0.0000 | 34,806,349 | 100.00% | 0.04% |
| July 17, 2023 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Not found | M | Common Stock | 12500 | $2.64 | 12,500.0000 | 34,806,349 | 9999.99% | 0.04% |
| Feb. 9, 2023 | 89bio, Inc. | $ETNB | LAPORTE KATHLEEN | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |